219 related articles for article (PubMed ID: 9528858)
21. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors.
Stirzaker C; Millar DS; Paul CL; Warnecke PM; Harrison J; Vincent PC; Frommer M; Clark SJ
Cancer Res; 1997 Jun; 57(11):2229-37. PubMed ID: 9187126
[TBL] [Abstract][Full Text] [Related]
22. Methylation-sensitive, single-strand conformation analysis (MS-SSCA): A rapid method to screen for and analyze methylation.
Bianco T; Hussey D; Dobrovic A
Hum Mutat; 1999; 14(4):289-93. PubMed ID: 10502775
[TBL] [Abstract][Full Text] [Related]
23. Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors.
Parrella P; Poeta ML; Gallo AP; Prencipe M; Scintu M; Apicella A; Rossiello R; Liguoro G; Seripa D; Gravina C; Rabitti C; Rinaldi M; Nicol T; Tommasi S; Paradiso A; Schittulli F; Altomare V; Fazio VM
Clin Cancer Res; 2004 Aug; 10(16):5349-54. PubMed ID: 15328171
[TBL] [Abstract][Full Text] [Related]
24. A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylation.
Alvarez S; Diaz-Uriarte R; Osorio A; Barroso A; Melchor L; Paz MF; Honrado E; Rodríguez R; Urioste M; Valle L; Díez O; Cigudosa JC; Dopazo J; Esteller M; Benitez J
Clin Cancer Res; 2005 Feb; 11(3):1146-53. PubMed ID: 15709182
[TBL] [Abstract][Full Text] [Related]
25. CpG dinucleotide methylation of the CYP19 I.3/II promoter modulates cAMP-stimulated aromatase activity.
Demura M; Bulun SE
Mol Cell Endocrinol; 2008 Feb; 283(1-2):127-32. PubMed ID: 18201819
[TBL] [Abstract][Full Text] [Related]
26. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
[TBL] [Abstract][Full Text] [Related]
27. Dynamic changes in DNA methylation during thermal control establishment affect CREB binding to the brain-derived neurotrophic factor promoter.
Yossifoff M; Kisliouk T; Meiri N
Eur J Neurosci; 2008 Dec; 28(11):2267-77. PubMed ID: 19046370
[TBL] [Abstract][Full Text] [Related]
28. Heterogenous point mutations in the BRCA1 breast cancer susceptibility gene occur in high frequency at the site of homonucleotide tracts, short repeats and methylatable CpG/CpNpG motifs.
Rodenhiser D; Chakraborty P; Andrews J; Ainsworth P; Mancini D; Lopes E; Singh S
Oncogene; 1996 Jun; 12(12):2623-9. PubMed ID: 8700521
[TBL] [Abstract][Full Text] [Related]
29. BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.
Baldwin RL; Nemeth E; Tran H; Shvartsman H; Cass I; Narod S; Karlan BY
Cancer Res; 2000 Oct; 60(19):5329-33. PubMed ID: 11034065
[TBL] [Abstract][Full Text] [Related]
30. Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors.
Krop I; Maguire P; Lahti-Domenici J; Lodeiro G; Richardson A; Johannsdottir HK; Nevanlinna H; Borg A; Gelman R; Barkardottir RB; Lindblom A; Polyak K
Cancer Res; 2003 May; 63(9):2024-7. PubMed ID: 12727813
[TBL] [Abstract][Full Text] [Related]
31. GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas.
Rønneberg JA; Tost J; Solvang HK; Alnaes GI; Johansen FE; Brendeford EM; Yakhini Z; Gut IG; Lønning PE; Børresen-Dale AL; Gabrielsen OS; Kristensen VN
Cancer Res; 2008 Jul; 68(14):5562-71. PubMed ID: 18632608
[TBL] [Abstract][Full Text] [Related]
32. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
33. A consensus DNA recognition motif for two KDWK transcription factors identifies flexible-length, CpG-methylation sensitive cognate binding sites in the majority of human promoters.
Burnett E; Christensen J; Tattersall P
J Mol Biol; 2001 Dec; 314(5):1029-39. PubMed ID: 11743720
[TBL] [Abstract][Full Text] [Related]
34. Activation of Galectin-1 gene in human hepatocellular carcinoma involves methylation-sensitive complex formations at the transcriptional upstream and downstream elements.
Kondoh N; Hada A; Ryo A; Shuda M; Arai M; Matsubara O; Kimura F; Wakatsuki T; Yamamoto M
Int J Oncol; 2003 Dec; 23(6):1575-83. PubMed ID: 14612929
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequences.
Lu A; Gupta A; Li C; Ahlborn TE; Ma Y; Shi EY; Liu J
Oncogene; 2001 Aug; 20(37):5173-85. PubMed ID: 11526506
[TBL] [Abstract][Full Text] [Related]
36. Effects of methylation of non-CpG sequence in the promoter region on the expression of human synaptotagmin XI (syt11).
Inoue S; Oishi M
Gene; 2005 Mar; 348():123-34. PubMed ID: 15777718
[TBL] [Abstract][Full Text] [Related]
37. Analysis of methylation-sensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer.
Wang W; Huper G; Guo Y; Murphy SK; Olson JA; Marks JR
Oncogene; 2005 Apr; 24(16):2705-14. PubMed ID: 15735726
[TBL] [Abstract][Full Text] [Related]
38. Characterization of a negative transcriptional element in the BRCA1 promoter.
MacDonald G; Stramwasser M; Mueller CR
Breast Cancer Res; 2007; 9(4):R49. PubMed ID: 17663789
[TBL] [Abstract][Full Text] [Related]
39. Methylation status and chromatin structure of an early response gene (ornithine decarboxylase) in resting and stimulated NIH-3T3 fibroblasts.
Laitinen J; Hölttä E
J Cell Biochem; 1994 Jun; 55(2):155-67. PubMed ID: 7522236
[TBL] [Abstract][Full Text] [Related]
40. DNA binding sites for putative methylation boundaries in the unmethylated region of the BRCA1 promoter.
Butcher DT; Mancini-DiNardo DN; Archer TK; Rodenhiser DI
Int J Cancer; 2004 Sep; 111(5):669-78. PubMed ID: 15252835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
